SlideShare ist ein Scribd-Unternehmen logo
1 von 8
Marissa Uhlhorn
End Stage Liver Disease with GERD and Bleeding Esophageal Varices
FSHN 450
Fall 2015
Due Date: November 6, 2015
I have not given or received any unauthorized assistance on this assignment
_______________________________________________________
End Stage Liver Disease with GERD and Bleeding Esophageal Varices
FSHN 450
Fall 2015
Due Date: November 6, 2015
What was the cause of the weight gain?
The cause of the patient's weight gain is most likely due to edema, which is from water retention
and swelling of extremities. This is indicative of his low serum albumin levels. He was also
admitted with ascites as seen with fluid accumulation in his abdomen.
His weight gain could also be attributed to the diet he consumes. A large number of calories come
from his 7 shots of bourbon and 6 cans of beer he is consuming each day. This patient also
consumes highly processed foods, which typically are high in saturated fats and sodium.
What is the purpose of each of the patient’s medications? List any important drug/nutrient
interactions.
TUMS
o Purpose: Antacid, phosphate binder, antidiarrheal
o Diet: insure adequate fluid intake/hydration, take separately from large amounts of high
fiber, high oxalate or high phytate foods
Zantac
o Purpose: Antiulcer, anti-GERD, antisecretory
o Nutrient interaction: decreased FE & Vit B12 absorption, Mg or Al/Mg antacids
decreased drug absorption
Lisinopril
o Purpose: Antihypertensive, CHF treatment, post MI treatment
o Nutrient interaction: insure adequate fluid intake, decreased Na and cal may be
recommended. Caution with K supplements, avoid natural licorice, decreased weight
reported (anorexia)
Lactulose
o Purpose: laxative to treat increased ammonia levels
o Nutrient interactions: High fiber (with 1500-2000 ml fluid/day) to prevent constipation,
not with lactose or galactose restricted diet. Do not take concomitantly with antacids, Ca
or Mg supplements. Drug increased absorption of Ca & Mg
Octreotide
o Purpose: Antidiarrheal, also used for acute bleeding esophageal varices treatment
o Nutrient Interactions: May cause fat and fat-soluble vitamin malabsorption and delay
gastric emptying. Alters insulin, growth hormone, thyroid hormone and glucagon levels
Vitamin K
o Purpose: Treat hypoprothrobinemia and increase blood clotting
o Nutrient Interactions: Maintain consistent Vit K intake if taking anticoagulant, adequate
intake for males: 120 micrograms/day, no documented toxicity.
Compazine
o Purpose: Antipyschotic, antiemetic, antianxiety
o Nutrient interactions: limit caffeine, increased appetite, increased weight, and increased
need for Rib. May decrease absorption of Vit B12.
Morphine
o Purpose: Analgesic, narcotic, opioid
o Nutrient interactions: anorexia (decreased weight), increased thirst, dehydration
Albumin iv
o Purpose: Can be used to treat edema, hypovolemia, hypoalbuminemia in critically ill or
bleeding patients
Furosamide iv
o Purpose: Antihypertensive and diuretic.
o Nutrient interaction: May deplete potassium levels, can lead to anorexia and increased
thirst.
Why was a surgical jejeunostomy tube placed?
Due to the patient's history of alcoholism, his intestinal mucosa is most likely severely damaged.
This would impair digestion and absorption of nutrients, resulting in malnutrition. He would also
most likely have B1 deficiency and poor iron and folate absorption. In addition, the cirrhosis has
caused esophageal varicies causing esophageal veins to bleed easily and become swollen or weak.
Because of all of these severe factors, the patient needs a surgical jejeunostomy tube so that he
can properly absorb nutrients and avoid further malnutrition.
Evaluate the patient’s nutrient needs and prescribe a tube feeding including type and
brand name, total volume and rate. Include a start rate and progression. Include ONLY
the Assessment section of the ADIME at this point.
Energy Needs: 30-35 kcal/kg BW/day
30-35 kcal * 88.2 kg= 2,646- 3,087 kcal/kg BW/day
Fat: Moderate- as tolerated: 25-35-en%
RANGE:
0.25*2,646= 661.5kcal/9g=73.5 g fat/day
0.25 * 3,087=771.8kcal/9g=85.8 g fat/day
0.35*2,646=926.1 kcal/9g=102.9 g fat/day
0.35* 3,087=1,080.5kcal/9g= 120.0 g fat/day
Protein Needs (clinically stable): 1.0-1.2 g/Kg BW/day
1.0-1.2g * 88.2 kg= 88.2-105.8 g/Kg BW/day
Other Vitamins/Minerals:
B12, B6, Niacin, Folic Acid for alcoholism
Iron with anemia??
Zinc and Magnesium for alcoholism
Nutrihep
1.5 kcal/ml
Total volume: 2,646-3,087kcal/1.5= 1,764 ml-2,058ml
Rate: 1,764ml-2,058ml/24 hr= 73.5ml/hr-85.8ml/hr
Start Rate: ¼ goal rate: 73.5ml/hr-85.8ml/hr *0.25=18.4 ml/hr-21.45ml/hr
Progression: Advance by 20 ml every 8-12 hrs until final volume is reached.
Assessment:
Current diagnosis: Upper GI Bleed, Cirrhosis
• Anthropometrics
◦ 57 year old male
◦ 5' 7”, 194 # (BMI: 30.4- obese)- gained 4 pounds in past 11 days
◦ BP 128/80- slightly high
◦ Pulse 90-normal
◦ RR 16- higher end of normal
◦ Temp 98.9- normal
Biochemical Indicators
◦ Na (low), Cl (low), CO2 (low), Creatinine (high), PTT (high), Hgb (low), Hct (low),
Albumin (low), TG (high), Total Cholesterol (high risk)
• Physical
◦ N&V
◦ Abdominal pain radiating to Rt side
◦ Presented with scleral icterus (possible jaundice)
◦ Increased abdominal girth
◦ Ascites- accumulation of fluid causing abdominal swelling
◦ Black stools
◦ Gained 4 pounds in 11 days (upon next visit)
• Medical History
◦ Hypertension
◦ Cholecystectomy
◦ Alcoholism
◦ Medications at home: TUMS, Zantac, Lisinopril
• Hospital medications: Lactulose, Octreotide, Vitamin K, Compazine, Morphine, albumin
iv, furosamide iv
• Social/Family History
◦ Divorced for 15 years.
◦ Mother living but father died at age 65 from CHF
◦ Living siblings: Brother 53 has atherosclerotic heart disease
▪ Brother 40 and sister 46 in apparent good health
▪ Sister age 48 is obese
• Diet History
◦ High calories coming from 7 shots of bourbon/day and 6 beers/day
◦ High calories, saturated fats, and sodium coming from processed foods (hot dog,
chips, condiments, pasta/macaroni and cheese
◦ Low intake (if at all) of fruits and vegetables
◦ Low protein consumption
List the probable reasons for the tube feeding intolerance in this patient?
Tube feeding intolerance is seen in this patient due to the damage of the intestinal mucosa, which
includes the jejunum. This could result in the patient’s malabsorption of key nutrients and overall
calorie consumption.
You do not need to calculate a TPN but you should reevaluate protein and Kcal needs.
This patient is most likely grade 3 of hepatic encephalopathy (due to being disoriented to
time/place, mild asterixis and edema), therefore his energy and protein needs must be adjusted.
Energy Needs: still 30-35kcal/kg BW/day
30-35 kcal * 88.2 kg= 2,646- 3,087 kcal/kg BW/day
Protein Needs: Grade 3 requires 0.5 g/kg for 2-3 day and increase by 0.25 g/kg
0.5g * 88.2 kg= 44.1 g/kg BW/day (for 2-3 days) than increase to 0.75 g * 88.2 kg= 66.15 g/kg
Why was Hepatamine® ordered and what at is the drawback to using this product?
This is given to patients with hepatic encephalopathy and cirrhosis. It also provides additional
nutrition support. A possible drawback would be that it may cause hyperglycemia which may
require insulin injections.
Why was a soft diet ordered?
A soft diet is recommended to avoid bleeding of the varicose veins. This would occur due to the
inability of the veins in the esophagus to drain, resulting in bulges that may tear or burst.
Conduct a follow-up nutrition assessment and report in ADIME format for transition to
oral diet (on 7/11) Develop three PES statements, one in each domain and plan an
itervention and follow-up for each nutrition diagnosis.
7/1 Laboratory
Na 122 mEq/L
K 4.1 mEq/L
Cl 98 mEq/L
CO2 10 mmol/L
Glu 93 mg/dl
BUN 18 mg/dl
Creat 1.6 mg/dl
PTT 43.1 seconds (reference: 23.7 - 32.7 seconds)
RBC 2.88 x106
/mm3
Hgb 9.1 g/dl
Hct 26.9 %
Albumin 2.6 g/dl
Assessment:
Admittance diagnosis: Upper GI Bleed, Cirrhosis
• Anthropometric:
◦ 57 year old male
◦ Previous visit (6/17) vitals:
▪ 5' 7”, 194 # (BMI: 30.4- obese)
▪ BP 128/80- slightly high
▪ Pulse 90-normal
▪ RR 16- higher end of normal
▪ Temp 98.9- normal
*No recorded 7/1 or 7/11 vitals
Biochemical Indicators
(7/1): Na (low), CO2 (low), Creatinine (high), PTT (high), Hgb (low), Hct (low), Albumin (low).
• Physical
◦ Stabilized
◦ Diagnosis: Chronic alcoholic cirrhosis with stable encephalopathy and esophageal
varices.
• Medical History
◦ Hypertension
◦ Cholecystectomy
◦ Alcoholism
◦ Medications at home: TUMS, Zantac, Lisinopril
• Hospital medications: Lactulose, Octreotide, Vitamin K, Compazine, Morphine, albumin
iv, furosamide iv
• (7/1): Tri-luminal catheter, TPN with Hepatamine® (limit 1500 ml).
• Social/Family History
◦ Divorced for 15 years.
◦ Mother living but father died at age 65 from CHF
◦ Living siblings: Brother 53 has atherosclerotic heart disease
▪ Brother 40 and sister 46 in apparent good health
▪ Sister age 48 is obese
• Previous diet history
◦ 6/17:
▪ High calories coming from 7 shots of bourbon/day and 6 beers/day
▪ High calories, saturated fats, and sodium coming from processed foods (hot dog,
chips, condiments, pasta/macaroni and cheese
▪ Low intake (if at all) of fruits and vegetables
▪ Low protein consumption
◦ 7/1:
▪ Tri-luminal catheter, TPN with Hepatamine® (limit 1500 ml).
◦ 7/11- diet prescription:
▪ TPN tapered and patient diet order changed to clear liquid progressing to oral diet
as tolerated. Fluid restricted to 2000 ml/day, 2300 mg sodium, soft diet.
Diagnosis:
1) Intake Domain: Malnutrition R/T diagnosis of chronic alcoholic cirrhosis AEB increased
creatinine and albumin levels (on 7/1) and previous TPN administration
Intervention:
• Discuss with the patient the importance of a balanced diet (once tolerated)
• Educate the patient about the harmful effects of alcoholism on his body
• Have the client come up with healthy foods to incorporate into his day
• Encourage the client to keep a food/fluid record for future analysis
Follow-up:
• Analyze the patient's food and fluid record (see if it meets the fluid and sodium
recommendations)
• Monitor creatinine levels
• Assess patient's tolerance to transition to soft oral diet
2) Clinical Domain: Altered GI function R/T diagnosis of chronic alcoholic cirrhosis AEB
increased abdominal girth secondary to ascites.
Intervention:
• Encourage client to decrease alcohol consumption (or quit all together)
• Encourage client to consume a balanced diet (as tolerated) and to keep a
food/fluid diary
• Encourage client eat smaller more frequent meals to avoid further symptoms of
GERD.
Follow-up:
• Assess the client’s compliance to decreasing/quitting alcohol consumption
• Analyze food and fluid diary
• Monitor lab values of concern: (7/1): Na (low), CO2 (low), Creatinine (high), PTT
(high), Hgb (low), Hct (low), Albumin (low).
3) Behavioral Domain: Undesirable food choices R/T excessive alcohol consumption,
sodium, and fat intake AEB dietary recall provided in admittance.
Intervention:
• Educate client about the effects of alcoholism
• Encourage client to come up with healthy meal/snack choices
• Assess the client’s ability to cook and give ideas of unprocessed meals to make
• Encourage activities/hobbies to take the place of drinking during the day
Follow-up:
• Assess the client’s compliance in decreasing/quitting excessive alcohol
consumption
• Assess the client’s progress in making healthier unprocessed meals
• Assess the client’s knowledge about healthy food options to consume
• Assess the client’s progress in choosing activities to prevent excess alcohol
consumption.

Weitere ähnliche Inhalte

Was ist angesagt?

Liver Disease Case Study
Liver Disease Case StudyLiver Disease Case Study
Liver Disease Case StudySonja Silva
 
Carbohydrate Counting
Carbohydrate CountingCarbohydrate Counting
Carbohydrate Countingjeska62
 
Kidney Disease Case Study
Kidney Disease Case StudyKidney Disease Case Study
Kidney Disease Case Studylusimartin
 
Low Purine Diet For Gout
Low Purine Diet For GoutLow Purine Diet For Gout
Low Purine Diet For GoutCureGout
 
parenteral and enteral nutrition
parenteral and enteral nutritionparenteral and enteral nutrition
parenteral and enteral nutritionShima Ghavimi, MD
 
Medical Nutrition Therapy in Diabetes
Medical Nutrition Therapy in DiabetesMedical Nutrition Therapy in Diabetes
Medical Nutrition Therapy in DiabetesIris Thiele Isip-Tan
 
Nutrition for the surgical patient by Dr. Ali Mujtaba
Nutrition for the surgical patient by Dr. Ali MujtabaNutrition for the surgical patient by Dr. Ali Mujtaba
Nutrition for the surgical patient by Dr. Ali MujtabaDr Ali MUJTABA
 
Understanding Uric Acid Diet
Understanding Uric Acid DietUnderstanding Uric Acid Diet
Understanding Uric Acid DietCureGout
 
Nutritional management of diarrhea
Nutritional management of diarrheaNutritional management of diarrhea
Nutritional management of diarrheaManu Kaushik
 
bariatric nutrition: a way to manage obesity
bariatric nutrition: a way to manage obesitybariatric nutrition: a way to manage obesity
bariatric nutrition: a way to manage obesityDr. Swati Shukla
 
Hypertension and Cardiovascular Disease Clinical Nutrition Case Study
Hypertension and Cardiovascular Disease Clinical Nutrition Case StudyHypertension and Cardiovascular Disease Clinical Nutrition Case Study
Hypertension and Cardiovascular Disease Clinical Nutrition Case StudyDawnAnderson14
 
Nutrition therapy work shop dawly first part 2017
Nutrition therapy work shop dawly   first part  2017Nutrition therapy work shop dawly   first part  2017
Nutrition therapy work shop dawly first part 2017FarragBahbah
 
Case Studies in Clinical Nutrition
Case Studies in Clinical NutritionCase Studies in Clinical Nutrition
Case Studies in Clinical NutritionAnahita Sharma
 

Was ist angesagt? (20)

Diet in ckd
Diet in ckdDiet in ckd
Diet in ckd
 
Liver Disease Case Study
Liver Disease Case StudyLiver Disease Case Study
Liver Disease Case Study
 
Case Study
Case StudyCase Study
Case Study
 
CASE STUDY (Q5)
CASE STUDY (Q5)CASE STUDY (Q5)
CASE STUDY (Q5)
 
Carbohydrate Counting
Carbohydrate CountingCarbohydrate Counting
Carbohydrate Counting
 
Kidney Disease Case Study
Kidney Disease Case StudyKidney Disease Case Study
Kidney Disease Case Study
 
Low Purine Diet For Gout
Low Purine Diet For GoutLow Purine Diet For Gout
Low Purine Diet For Gout
 
parenteral and enteral nutrition
parenteral and enteral nutritionparenteral and enteral nutrition
parenteral and enteral nutrition
 
Medical Nutrition Therapy in Diabetes
Medical Nutrition Therapy in DiabetesMedical Nutrition Therapy in Diabetes
Medical Nutrition Therapy in Diabetes
 
MNT in chronic renal failure
MNT in chronic renal failureMNT in chronic renal failure
MNT in chronic renal failure
 
Nutrition for the surgical patient by Dr. Ali Mujtaba
Nutrition for the surgical patient by Dr. Ali MujtabaNutrition for the surgical patient by Dr. Ali Mujtaba
Nutrition for the surgical patient by Dr. Ali Mujtaba
 
Understanding Uric Acid Diet
Understanding Uric Acid DietUnderstanding Uric Acid Diet
Understanding Uric Acid Diet
 
Nutrition case study
Nutrition case studyNutrition case study
Nutrition case study
 
Nutritional management of diarrhea
Nutritional management of diarrheaNutritional management of diarrhea
Nutritional management of diarrhea
 
bariatric nutrition: a way to manage obesity
bariatric nutrition: a way to manage obesitybariatric nutrition: a way to manage obesity
bariatric nutrition: a way to manage obesity
 
Hypertension and Cardiovascular Disease Clinical Nutrition Case Study
Hypertension and Cardiovascular Disease Clinical Nutrition Case StudyHypertension and Cardiovascular Disease Clinical Nutrition Case Study
Hypertension and Cardiovascular Disease Clinical Nutrition Case Study
 
Applied nutrition for thyroid health
Applied nutrition for thyroid health Applied nutrition for thyroid health
Applied nutrition for thyroid health
 
Nutrition in Stroke
Nutrition in StrokeNutrition in Stroke
Nutrition in Stroke
 
Nutrition therapy work shop dawly first part 2017
Nutrition therapy work shop dawly   first part  2017Nutrition therapy work shop dawly   first part  2017
Nutrition therapy work shop dawly first part 2017
 
Case Studies in Clinical Nutrition
Case Studies in Clinical NutritionCase Studies in Clinical Nutrition
Case Studies in Clinical Nutrition
 

Andere mochten auch

Debate sobre el acuerdo final entre el gobierno y las farc. 2016
Debate sobre el acuerdo final entre el gobierno y las farc. 2016Debate sobre el acuerdo final entre el gobierno y las farc. 2016
Debate sobre el acuerdo final entre el gobierno y las farc. 2016Edgar Devia Góngora
 
Actividad grupal. Presupuesto
Actividad grupal. PresupuestoActividad grupal. Presupuesto
Actividad grupal. Presupuestozule_22
 
ஐரோப்பியர் காலம் 7.1 & 7.2
ஐரோப்பியர் காலம் 7.1 & 7.2ஐரோப்பியர் காலம் 7.1 & 7.2
ஐரோப்பியர் காலம் 7.1 & 7.2DHIVEK MOHAN
 
“EcoBlock” Neighborhoods The Right Scale for Zero Carbon Development?
“EcoBlock” Neighborhoods The Right Scale for Zero Carbon Development? “EcoBlock” Neighborhoods The Right Scale for Zero Carbon Development?
“EcoBlock” Neighborhoods The Right Scale for Zero Carbon Development? Penn Institute for Urban Research
 
[MT4 EA] SINIGAMI 소개
[MT4 EA] SINIGAMI 소개[MT4 EA] SINIGAMI 소개
[MT4 EA] SINIGAMI 소개forexliga
 
El juego heurístico pdf
El juego heurístico pdfEl juego heurístico pdf
El juego heurístico pdfCarsuarezcundin
 
Romania's success in software outsourcing
Romania's success in software outsourcingRomania's success in software outsourcing
Romania's success in software outsourcingComputaris
 
NHHC chapter 19 outline
NHHC chapter 19 outlineNHHC chapter 19 outline
NHHC chapter 19 outlineKellyGCDET
 
Culture Summit 2016 - How to Scale Culture with Janelle Gale, VP of HR at Fac...
Culture Summit 2016 - How to Scale Culture with Janelle Gale, VP of HR at Fac...Culture Summit 2016 - How to Scale Culture with Janelle Gale, VP of HR at Fac...
Culture Summit 2016 - How to Scale Culture with Janelle Gale, VP of HR at Fac...Culture Summit
 
Lorena Fernandez presentación proyecto ley Mutualia
Lorena Fernandez presentación proyecto ley Mutualia Lorena Fernandez presentación proyecto ley Mutualia
Lorena Fernandez presentación proyecto ley Mutualia mutualia
 
Top 10 security risks for mobile backend developers
Top 10 security risks for mobile backend developersTop 10 security risks for mobile backend developers
Top 10 security risks for mobile backend developersJiri Danihelka
 
strategies for closing 5 gaps of service
strategies for closing 5 gaps of servicestrategies for closing 5 gaps of service
strategies for closing 5 gaps of serviceaman raj
 

Andere mochten auch (18)

Debate sobre el acuerdo final entre el gobierno y las farc. 2016
Debate sobre el acuerdo final entre el gobierno y las farc. 2016Debate sobre el acuerdo final entre el gobierno y las farc. 2016
Debate sobre el acuerdo final entre el gobierno y las farc. 2016
 
Actividad grupal. Presupuesto
Actividad grupal. PresupuestoActividad grupal. Presupuesto
Actividad grupal. Presupuesto
 
ஐரோப்பியர் காலம் 7.1 & 7.2
ஐரோப்பியர் காலம் 7.1 & 7.2ஐரோப்பியர் காலம் 7.1 & 7.2
ஐரோப்பியர் காலம் 7.1 & 7.2
 
“EcoBlock” Neighborhoods The Right Scale for Zero Carbon Development?
“EcoBlock” Neighborhoods The Right Scale for Zero Carbon Development? “EcoBlock” Neighborhoods The Right Scale for Zero Carbon Development?
“EcoBlock” Neighborhoods The Right Scale for Zero Carbon Development?
 
Improving Student Outcomes Through Data Dashboards
Improving Student Outcomes Through Data DashboardsImproving Student Outcomes Through Data Dashboards
Improving Student Outcomes Through Data Dashboards
 
[MT4 EA] SINIGAMI 소개
[MT4 EA] SINIGAMI 소개[MT4 EA] SINIGAMI 소개
[MT4 EA] SINIGAMI 소개
 
Streamlining data usage in michigan using ed fi
Streamlining data usage in michigan using ed fiStreamlining data usage in michigan using ed fi
Streamlining data usage in michigan using ed fi
 
Seed pitch
Seed pitchSeed pitch
Seed pitch
 
El juego heurístico pdf
El juego heurístico pdfEl juego heurístico pdf
El juego heurístico pdf
 
Romania's success in software outsourcing
Romania's success in software outsourcingRomania's success in software outsourcing
Romania's success in software outsourcing
 
NHHC chapter 19 outline
NHHC chapter 19 outlineNHHC chapter 19 outline
NHHC chapter 19 outline
 
Culture Summit 2016 - How to Scale Culture with Janelle Gale, VP of HR at Fac...
Culture Summit 2016 - How to Scale Culture with Janelle Gale, VP of HR at Fac...Culture Summit 2016 - How to Scale Culture with Janelle Gale, VP of HR at Fac...
Culture Summit 2016 - How to Scale Culture with Janelle Gale, VP of HR at Fac...
 
Lorena Fernandez presentación proyecto ley Mutualia
Lorena Fernandez presentación proyecto ley Mutualia Lorena Fernandez presentación proyecto ley Mutualia
Lorena Fernandez presentación proyecto ley Mutualia
 
Web 2.0
Web 2.0Web 2.0
Web 2.0
 
Imthiyaz A M - CV
Imthiyaz A M - CVImthiyaz A M - CV
Imthiyaz A M - CV
 
Top 10 security risks for mobile backend developers
Top 10 security risks for mobile backend developersTop 10 security risks for mobile backend developers
Top 10 security risks for mobile backend developers
 
Animals
AnimalsAnimals
Animals
 
strategies for closing 5 gaps of service
strategies for closing 5 gaps of servicestrategies for closing 5 gaps of service
strategies for closing 5 gaps of service
 

Ähnlich wie Liver disease case study

CDK case study pdf nov 13
CDK case study pdf nov 13CDK case study pdf nov 13
CDK case study pdf nov 13Carolina chaves
 
Obesity: nutrients modulators of neuropeptides and neurotransmmitters
Obesity: nutrients modulators of neuropeptides and neurotransmmitters Obesity: nutrients modulators of neuropeptides and neurotransmmitters
Obesity: nutrients modulators of neuropeptides and neurotransmmitters Nutriline SRL
 
Obesidad: nutrientes moduladores de neuropeptidos y neurotransmisores
Obesidad: nutrientes moduladores de neuropeptidos y neurotransmisoresObesidad: nutrientes moduladores de neuropeptidos y neurotransmisores
Obesidad: nutrientes moduladores de neuropeptidos y neurotransmisoresNutriline SRL
 
Kidneydisease case study
Kidneydisease case studyKidneydisease case study
Kidneydisease case studyMarissa Uhlhorn
 
liver disease cse 2015
liver disease cse 2015liver disease cse 2015
liver disease cse 2015Carly Gehler
 
Liver Disease Case Study
Liver Disease Case StudyLiver Disease Case Study
Liver Disease Case StudyAlysse Milano
 
6d manufacture of total parenteral nutrition
6d manufacture of total parenteral nutrition6d manufacture of total parenteral nutrition
6d manufacture of total parenteral nutritionChanukya Vanam . Dr
 
liver disease case study
liver disease case studyliver disease case study
liver disease case studyRachel Mostek
 
Nutrition therapy work shop dawly second part 2017
Nutrition therapy work shop dawly   second part  2017Nutrition therapy work shop dawly   second part  2017
Nutrition therapy work shop dawly second part 2017FarragBahbah
 
FSHN 450 renal case study
FSHN 450 renal case studyFSHN 450 renal case study
FSHN 450 renal case studyAnya Guy
 
Ramadan fasting and liver diseases
Ramadan fasting and liver diseasesRamadan fasting and liver diseases
Ramadan fasting and liver diseasesFarragBahbah
 
Anorexia Nervosa Case Study
Anorexia Nervosa Case StudyAnorexia Nervosa Case Study
Anorexia Nervosa Case StudyRoanna Martin
 
Enteral and Parenteral Nutrition
Enteral and Parenteral Nutrition Enteral and Parenteral Nutrition
Enteral and Parenteral Nutrition Areej Abu Hanieh
 
Cystic Fibrosis Case Study new
Cystic Fibrosis Case Study newCystic Fibrosis Case Study new
Cystic Fibrosis Case Study newMegan Smith
 
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptx
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptxTOTAL PARETERAL NUTRITION and Enteral Nutrition.pptx
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptxshaziapharmacist118
 
Total parental nutrition
Total parental nutritionTotal parental nutrition
Total parental nutritionBe Akash Sah
 

Ähnlich wie Liver disease case study (20)

Liver Disease and GERD
Liver Disease and GERDLiver Disease and GERD
Liver Disease and GERD
 
CDK case study pdf nov 13
CDK case study pdf nov 13CDK case study pdf nov 13
CDK case study pdf nov 13
 
Obesity: nutrients modulators of neuropeptides and neurotransmmitters
Obesity: nutrients modulators of neuropeptides and neurotransmmitters Obesity: nutrients modulators of neuropeptides and neurotransmmitters
Obesity: nutrients modulators of neuropeptides and neurotransmmitters
 
Obesidad: nutrientes moduladores de neuropeptidos y neurotransmisores
Obesidad: nutrientes moduladores de neuropeptidos y neurotransmisoresObesidad: nutrientes moduladores de neuropeptidos y neurotransmisores
Obesidad: nutrientes moduladores de neuropeptidos y neurotransmisores
 
CKD Case Study
CKD Case StudyCKD Case Study
CKD Case Study
 
case study T2DM
case study T2DMcase study T2DM
case study T2DM
 
Kidneydisease case study
Kidneydisease case studyKidneydisease case study
Kidneydisease case study
 
liver disease cse 2015
liver disease cse 2015liver disease cse 2015
liver disease cse 2015
 
ckd case.f15 (2)
ckd case.f15 (2)ckd case.f15 (2)
ckd case.f15 (2)
 
Liver Disease Case Study
Liver Disease Case StudyLiver Disease Case Study
Liver Disease Case Study
 
6d manufacture of total parenteral nutrition
6d manufacture of total parenteral nutrition6d manufacture of total parenteral nutrition
6d manufacture of total parenteral nutrition
 
liver disease case study
liver disease case studyliver disease case study
liver disease case study
 
Nutrition therapy work shop dawly second part 2017
Nutrition therapy work shop dawly   second part  2017Nutrition therapy work shop dawly   second part  2017
Nutrition therapy work shop dawly second part 2017
 
FSHN 450 renal case study
FSHN 450 renal case studyFSHN 450 renal case study
FSHN 450 renal case study
 
Ramadan fasting and liver diseases
Ramadan fasting and liver diseasesRamadan fasting and liver diseases
Ramadan fasting and liver diseases
 
Anorexia Nervosa Case Study
Anorexia Nervosa Case StudyAnorexia Nervosa Case Study
Anorexia Nervosa Case Study
 
Enteral and Parenteral Nutrition
Enteral and Parenteral Nutrition Enteral and Parenteral Nutrition
Enteral and Parenteral Nutrition
 
Cystic Fibrosis Case Study new
Cystic Fibrosis Case Study newCystic Fibrosis Case Study new
Cystic Fibrosis Case Study new
 
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptx
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptxTOTAL PARETERAL NUTRITION and Enteral Nutrition.pptx
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptx
 
Total parental nutrition
Total parental nutritionTotal parental nutrition
Total parental nutrition
 

Mehr von Marissa Uhlhorn

Complementary Herbs and Foods
Complementary Herbs and FoodsComplementary Herbs and Foods
Complementary Herbs and FoodsMarissa Uhlhorn
 
POSTER Influence of breastfeeding on infant allergy development (1)
POSTER Influence of breastfeeding on infant allergy development (1)POSTER Influence of breastfeeding on infant allergy development (1)
POSTER Influence of breastfeeding on infant allergy development (1)Marissa Uhlhorn
 
Community Nutrition Assignment 3
Community Nutrition Assignment 3Community Nutrition Assignment 3
Community Nutrition Assignment 3Marissa Uhlhorn
 

Mehr von Marissa Uhlhorn (7)

Complementary Herbs and Foods
Complementary Herbs and FoodsComplementary Herbs and Foods
Complementary Herbs and Foods
 
Recipes
RecipesRecipes
Recipes
 
practicum self-eval
practicum self-evalpracticum self-eval
practicum self-eval
 
POSTER Influence of breastfeeding on infant allergy development (1)
POSTER Influence of breastfeeding on infant allergy development (1)POSTER Influence of breastfeeding on infant allergy development (1)
POSTER Influence of breastfeeding on infant allergy development (1)
 
Community Nutrition Assignment 3
Community Nutrition Assignment 3Community Nutrition Assignment 3
Community Nutrition Assignment 3
 
Celiac Case Study
Celiac Case StudyCeliac Case Study
Celiac Case Study
 
Combo report
Combo reportCombo report
Combo report
 

Liver disease case study

  • 1. Marissa Uhlhorn End Stage Liver Disease with GERD and Bleeding Esophageal Varices FSHN 450 Fall 2015 Due Date: November 6, 2015 I have not given or received any unauthorized assistance on this assignment _______________________________________________________
  • 2. End Stage Liver Disease with GERD and Bleeding Esophageal Varices FSHN 450 Fall 2015 Due Date: November 6, 2015 What was the cause of the weight gain? The cause of the patient's weight gain is most likely due to edema, which is from water retention and swelling of extremities. This is indicative of his low serum albumin levels. He was also admitted with ascites as seen with fluid accumulation in his abdomen. His weight gain could also be attributed to the diet he consumes. A large number of calories come from his 7 shots of bourbon and 6 cans of beer he is consuming each day. This patient also consumes highly processed foods, which typically are high in saturated fats and sodium. What is the purpose of each of the patient’s medications? List any important drug/nutrient interactions. TUMS o Purpose: Antacid, phosphate binder, antidiarrheal o Diet: insure adequate fluid intake/hydration, take separately from large amounts of high fiber, high oxalate or high phytate foods Zantac o Purpose: Antiulcer, anti-GERD, antisecretory o Nutrient interaction: decreased FE & Vit B12 absorption, Mg or Al/Mg antacids decreased drug absorption Lisinopril o Purpose: Antihypertensive, CHF treatment, post MI treatment o Nutrient interaction: insure adequate fluid intake, decreased Na and cal may be recommended. Caution with K supplements, avoid natural licorice, decreased weight reported (anorexia) Lactulose o Purpose: laxative to treat increased ammonia levels o Nutrient interactions: High fiber (with 1500-2000 ml fluid/day) to prevent constipation, not with lactose or galactose restricted diet. Do not take concomitantly with antacids, Ca or Mg supplements. Drug increased absorption of Ca & Mg Octreotide o Purpose: Antidiarrheal, also used for acute bleeding esophageal varices treatment o Nutrient Interactions: May cause fat and fat-soluble vitamin malabsorption and delay gastric emptying. Alters insulin, growth hormone, thyroid hormone and glucagon levels Vitamin K o Purpose: Treat hypoprothrobinemia and increase blood clotting o Nutrient Interactions: Maintain consistent Vit K intake if taking anticoagulant, adequate intake for males: 120 micrograms/day, no documented toxicity.
  • 3. Compazine o Purpose: Antipyschotic, antiemetic, antianxiety o Nutrient interactions: limit caffeine, increased appetite, increased weight, and increased need for Rib. May decrease absorption of Vit B12. Morphine o Purpose: Analgesic, narcotic, opioid o Nutrient interactions: anorexia (decreased weight), increased thirst, dehydration Albumin iv o Purpose: Can be used to treat edema, hypovolemia, hypoalbuminemia in critically ill or bleeding patients Furosamide iv o Purpose: Antihypertensive and diuretic. o Nutrient interaction: May deplete potassium levels, can lead to anorexia and increased thirst. Why was a surgical jejeunostomy tube placed? Due to the patient's history of alcoholism, his intestinal mucosa is most likely severely damaged. This would impair digestion and absorption of nutrients, resulting in malnutrition. He would also most likely have B1 deficiency and poor iron and folate absorption. In addition, the cirrhosis has caused esophageal varicies causing esophageal veins to bleed easily and become swollen or weak. Because of all of these severe factors, the patient needs a surgical jejeunostomy tube so that he can properly absorb nutrients and avoid further malnutrition. Evaluate the patient’s nutrient needs and prescribe a tube feeding including type and brand name, total volume and rate. Include a start rate and progression. Include ONLY the Assessment section of the ADIME at this point. Energy Needs: 30-35 kcal/kg BW/day 30-35 kcal * 88.2 kg= 2,646- 3,087 kcal/kg BW/day Fat: Moderate- as tolerated: 25-35-en% RANGE: 0.25*2,646= 661.5kcal/9g=73.5 g fat/day 0.25 * 3,087=771.8kcal/9g=85.8 g fat/day 0.35*2,646=926.1 kcal/9g=102.9 g fat/day 0.35* 3,087=1,080.5kcal/9g= 120.0 g fat/day
  • 4. Protein Needs (clinically stable): 1.0-1.2 g/Kg BW/day 1.0-1.2g * 88.2 kg= 88.2-105.8 g/Kg BW/day Other Vitamins/Minerals: B12, B6, Niacin, Folic Acid for alcoholism Iron with anemia?? Zinc and Magnesium for alcoholism Nutrihep 1.5 kcal/ml Total volume: 2,646-3,087kcal/1.5= 1,764 ml-2,058ml Rate: 1,764ml-2,058ml/24 hr= 73.5ml/hr-85.8ml/hr Start Rate: ¼ goal rate: 73.5ml/hr-85.8ml/hr *0.25=18.4 ml/hr-21.45ml/hr Progression: Advance by 20 ml every 8-12 hrs until final volume is reached. Assessment: Current diagnosis: Upper GI Bleed, Cirrhosis • Anthropometrics ◦ 57 year old male ◦ 5' 7”, 194 # (BMI: 30.4- obese)- gained 4 pounds in past 11 days ◦ BP 128/80- slightly high ◦ Pulse 90-normal ◦ RR 16- higher end of normal ◦ Temp 98.9- normal Biochemical Indicators ◦ Na (low), Cl (low), CO2 (low), Creatinine (high), PTT (high), Hgb (low), Hct (low), Albumin (low), TG (high), Total Cholesterol (high risk) • Physical ◦ N&V ◦ Abdominal pain radiating to Rt side ◦ Presented with scleral icterus (possible jaundice) ◦ Increased abdominal girth ◦ Ascites- accumulation of fluid causing abdominal swelling ◦ Black stools ◦ Gained 4 pounds in 11 days (upon next visit) • Medical History ◦ Hypertension ◦ Cholecystectomy ◦ Alcoholism ◦ Medications at home: TUMS, Zantac, Lisinopril
  • 5. • Hospital medications: Lactulose, Octreotide, Vitamin K, Compazine, Morphine, albumin iv, furosamide iv • Social/Family History ◦ Divorced for 15 years. ◦ Mother living but father died at age 65 from CHF ◦ Living siblings: Brother 53 has atherosclerotic heart disease ▪ Brother 40 and sister 46 in apparent good health ▪ Sister age 48 is obese • Diet History ◦ High calories coming from 7 shots of bourbon/day and 6 beers/day ◦ High calories, saturated fats, and sodium coming from processed foods (hot dog, chips, condiments, pasta/macaroni and cheese ◦ Low intake (if at all) of fruits and vegetables ◦ Low protein consumption List the probable reasons for the tube feeding intolerance in this patient? Tube feeding intolerance is seen in this patient due to the damage of the intestinal mucosa, which includes the jejunum. This could result in the patient’s malabsorption of key nutrients and overall calorie consumption. You do not need to calculate a TPN but you should reevaluate protein and Kcal needs. This patient is most likely grade 3 of hepatic encephalopathy (due to being disoriented to time/place, mild asterixis and edema), therefore his energy and protein needs must be adjusted. Energy Needs: still 30-35kcal/kg BW/day 30-35 kcal * 88.2 kg= 2,646- 3,087 kcal/kg BW/day Protein Needs: Grade 3 requires 0.5 g/kg for 2-3 day and increase by 0.25 g/kg 0.5g * 88.2 kg= 44.1 g/kg BW/day (for 2-3 days) than increase to 0.75 g * 88.2 kg= 66.15 g/kg Why was Hepatamine® ordered and what at is the drawback to using this product? This is given to patients with hepatic encephalopathy and cirrhosis. It also provides additional nutrition support. A possible drawback would be that it may cause hyperglycemia which may require insulin injections. Why was a soft diet ordered? A soft diet is recommended to avoid bleeding of the varicose veins. This would occur due to the inability of the veins in the esophagus to drain, resulting in bulges that may tear or burst. Conduct a follow-up nutrition assessment and report in ADIME format for transition to
  • 6. oral diet (on 7/11) Develop three PES statements, one in each domain and plan an itervention and follow-up for each nutrition diagnosis. 7/1 Laboratory Na 122 mEq/L K 4.1 mEq/L Cl 98 mEq/L CO2 10 mmol/L Glu 93 mg/dl BUN 18 mg/dl Creat 1.6 mg/dl PTT 43.1 seconds (reference: 23.7 - 32.7 seconds) RBC 2.88 x106 /mm3 Hgb 9.1 g/dl Hct 26.9 % Albumin 2.6 g/dl Assessment: Admittance diagnosis: Upper GI Bleed, Cirrhosis • Anthropometric: ◦ 57 year old male ◦ Previous visit (6/17) vitals: ▪ 5' 7”, 194 # (BMI: 30.4- obese) ▪ BP 128/80- slightly high ▪ Pulse 90-normal ▪ RR 16- higher end of normal ▪ Temp 98.9- normal *No recorded 7/1 or 7/11 vitals Biochemical Indicators (7/1): Na (low), CO2 (low), Creatinine (high), PTT (high), Hgb (low), Hct (low), Albumin (low). • Physical ◦ Stabilized ◦ Diagnosis: Chronic alcoholic cirrhosis with stable encephalopathy and esophageal varices. • Medical History ◦ Hypertension ◦ Cholecystectomy ◦ Alcoholism ◦ Medications at home: TUMS, Zantac, Lisinopril • Hospital medications: Lactulose, Octreotide, Vitamin K, Compazine, Morphine, albumin iv, furosamide iv • (7/1): Tri-luminal catheter, TPN with Hepatamine® (limit 1500 ml). • Social/Family History ◦ Divorced for 15 years. ◦ Mother living but father died at age 65 from CHF
  • 7. ◦ Living siblings: Brother 53 has atherosclerotic heart disease ▪ Brother 40 and sister 46 in apparent good health ▪ Sister age 48 is obese • Previous diet history ◦ 6/17: ▪ High calories coming from 7 shots of bourbon/day and 6 beers/day ▪ High calories, saturated fats, and sodium coming from processed foods (hot dog, chips, condiments, pasta/macaroni and cheese ▪ Low intake (if at all) of fruits and vegetables ▪ Low protein consumption ◦ 7/1: ▪ Tri-luminal catheter, TPN with Hepatamine® (limit 1500 ml). ◦ 7/11- diet prescription: ▪ TPN tapered and patient diet order changed to clear liquid progressing to oral diet as tolerated. Fluid restricted to 2000 ml/day, 2300 mg sodium, soft diet. Diagnosis: 1) Intake Domain: Malnutrition R/T diagnosis of chronic alcoholic cirrhosis AEB increased creatinine and albumin levels (on 7/1) and previous TPN administration Intervention: • Discuss with the patient the importance of a balanced diet (once tolerated) • Educate the patient about the harmful effects of alcoholism on his body • Have the client come up with healthy foods to incorporate into his day • Encourage the client to keep a food/fluid record for future analysis Follow-up: • Analyze the patient's food and fluid record (see if it meets the fluid and sodium recommendations) • Monitor creatinine levels • Assess patient's tolerance to transition to soft oral diet 2) Clinical Domain: Altered GI function R/T diagnosis of chronic alcoholic cirrhosis AEB increased abdominal girth secondary to ascites. Intervention: • Encourage client to decrease alcohol consumption (or quit all together) • Encourage client to consume a balanced diet (as tolerated) and to keep a food/fluid diary
  • 8. • Encourage client eat smaller more frequent meals to avoid further symptoms of GERD. Follow-up: • Assess the client’s compliance to decreasing/quitting alcohol consumption • Analyze food and fluid diary • Monitor lab values of concern: (7/1): Na (low), CO2 (low), Creatinine (high), PTT (high), Hgb (low), Hct (low), Albumin (low). 3) Behavioral Domain: Undesirable food choices R/T excessive alcohol consumption, sodium, and fat intake AEB dietary recall provided in admittance. Intervention: • Educate client about the effects of alcoholism • Encourage client to come up with healthy meal/snack choices • Assess the client’s ability to cook and give ideas of unprocessed meals to make • Encourage activities/hobbies to take the place of drinking during the day Follow-up: • Assess the client’s compliance in decreasing/quitting excessive alcohol consumption • Assess the client’s progress in making healthier unprocessed meals • Assess the client’s knowledge about healthy food options to consume • Assess the client’s progress in choosing activities to prevent excess alcohol consumption.